Per Stirling Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$559K Buy
5,449
+194
+4% +$21.9K 0.06% 190
2025
Q4
$658K Buy
5,255
+97
+2% +$12.4K 0.07% 161
2025
Q3
$691K Buy
5,158
+28
+0.5% +$3.68K 0.08% 146
2025
Q2
$698K Buy
5,130
+22
+0.4% +$2.9K 0.09% 136
2025
Q1
$678K Sell
5,108
-181
-3% -$23K 0.1% 140
2024
Q4
$598K Sell
5,289
-87
-2% -$10.1K 0.08% 145
2024
Q3
$613K Sell
5,376
-1,495
-22% -$164K 0.09% 156
2024
Q2
$714K Buy
6,871
+4,802
+232% +$509K 0.12% 121
2024
Q1
$235K Sell
2,069
-150
-7% -$17.2K 0.04% 209
2023
Q4
$244K Sell
2,219
-1
-0% -$100 0.04% 189
2023
Q3
$215K Sell
2,220
-530
-19% -$55.7K 0.04% 185
2023
Q2
$300K Sell
2,750
-786
-22% -$83.8K 0.06% 160
2023
Q1
$358K Sell
3,536
-1,062
-23% -$112K 0.08% 139
2022
Q4
$505K Buy
+4,598
New +$476K 0.09% 124

Other funds holding ABT

Per Stirling Capital Management's ABT Position: Q1 2026 in Review

Per Stirling Capital Management increased its Abbott (ABT) stake by 3.7% in Q1 2026, buying an estimated $21.9K and bringing the position to 5,449 shares worth $559K. The position accounts for 0.06% of the portfolio, ranked #190.

Per Stirling Capital Management first reported a position in ABT in Q4 2022 and has held it in 14 quarters since. The position peaked at $714K in Q2 2024. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Per Stirling Capital Management held 5,449 shares of Abbott worth $559K as of Q1 2026.
  • Per Stirling Capital Management bought 194 Abbott shares in Q1 2026, an estimated $21.9K.
  • Abbott made up 0.06% of Per Stirling Capital Management's portfolio in Q1 2026, its #190 holding.
  • Per Stirling Capital Management first reported a position in Abbott in Q4 2022 and has held it in 14 quarters since.
  • Per Stirling Capital Management's Abbott position peaked at $714K in Q2 2024.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Per Stirling Capital Management's 13F filing for Q1 2026, filed 12 May 2026.